These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 20963473

  • 1. Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis.
    Szasz AM, Tokes AM, Micsinai M, Krenacs T, Jakab C, Lukacs L, Nemeth Z, Baranyai Z, Dede K, Madaras L, Kulka J.
    Clin Exp Metastasis; 2011 Jan; 28(1):55-63. PubMed ID: 20963473
    [Abstract] [Full Text] [Related]

  • 2. [Claudins as prognostic factors of breast cancer].
    Szász MA.
    Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinomas.
    Xu X, Jin H, Liu Y, Liu L, Wu Q, Guo Y, Yu L, Liu Z, Zhang T, Zhang X, Dong X, Quan C.
    Diagn Pathol; 2012 Mar 29; 7():33. PubMed ID: 22455563
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U, Mylonas I, Kuhn C, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K.
    Anticancer Res; 2007 Mar 29; 27(4A):1969-74. PubMed ID: 17649807
    [Abstract] [Full Text] [Related]

  • 8. Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.
    Shabani N, Mylonas I, Kunert-Keil C, Briese V, Janni W, Gerber B, Friese K, Jeschke U.
    Anticancer Res; 2005 Mar 29; 25(3A):1761-4. PubMed ID: 16033096
    [Abstract] [Full Text] [Related]

  • 9. High expression of claudin-1 protein in papillary thyroid tumor and its regional lymph node metastasis.
    Németh J, Németh Z, Tátrai P, Péter I, Somorácz A, Szász AM, Kiss A, Schaff Z.
    Pathol Oncol Res; 2010 Mar 29; 16(1):19-27. PubMed ID: 19578981
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas.
    Gerhard R, Ricardo S, Albergaria A, Gomes M, Silva AR, Logullo ÂF, Cameselle-Teijeiro JF, Paredes J, Schmitt F.
    Breast; 2012 Jun 29; 21(3):354-60. PubMed ID: 22464177
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tight junction protein claudin 4 in gastric carcinoma and its relation to lymphangiogenic activity.
    Shareef MM, Radi DM, Eid AM.
    Arab J Gastroenterol; 2015 Jun 29; 16(3-4):105-12. PubMed ID: 26526513
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.